If pharma companies want to hold their own in the current climate, they must embrace rather than resist market change.
Peter Muller
Advertisement
Peter Muller (Peter.muller@sh-p.com) is Managing Director, Schlafender Hase, Americas (www.text-verification.com)For the last 20 years, Peter Muller has worked on software and process improvement projects with Fortune 500 companies from various industries: Pharmaceutical, Consumer Goods, Food, Aerospace & Defense. He has a wealth of experience working with international clients to define their organization's goals and help them leverage new technologies to achieve productivity gains, process improvements and cost savings.
Articles by Peter Muller
If pharma companies want to hold their own in the current climate, they must embrace rather than resist market change, writes Peter Muller.
The lines between the pharma and food industries are blurring, presenting a great opportunity for life sciences firms to diversify - as long as they understand the regulatory differences, writes Peter Muller.
Advertisement
Latest Updated Articles
Food and Pharma: The Broadening Reach of RegulatorsPublished: August 1st 2016 | Updated:
- Life Sciences' Shifting Sands: 5 Trends that Threaten the Status Quo
Published: April 10th 2017 | Updated:
Life Sciences' Shifting Sands: 5 Trends that Threaten the Status QuoPublished: May 1st 2017 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: FDA Approves Novo Nordisk's Rybelsus and Roche’s Gazyva/Gazyvaro
2
Merck Planning $70 Billion Investment for US Expansion
3
Amazon and WeightWatchers Partner for DTC Weight Loss Medication Offerings
4
FDA Approves Tezspire as First Biologic Targeting TSLP for Chronic Rhinosinusitis With Nasal Polyps
5
